KEGG enrichment pathway analysis highlighted the downregulation of four genes such as Gpat4, Gpcpd1, Chkb, and Etnppl. These findings contribute to our understanding of the metabolic changes associated with MASLD. This evidence concerns the gene GPAT4 and metabolic dysfunction-associated steatotic liver disease.